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Materials and Methods
For all experiments we have used a VivoVision Systems, IVIS® 200 
Series,, Xenogen (Xenogen Corporation, Alameda USA), constituted
by a camera sensor  back thinned, back illuminated grade CCD 1 (2.7 
x 2.7cm, -90°C), with a minimal image pixel resolution of 20µm (pixel 
dimension 13.5µm, imaging pixels 2048 x 2048), quantum efficiency 
>85%  between 500 and 700nm, and > 30% between 400 and 900nm. 
Images will be acquired and analyzed with Living Image 2.6 software, 
Living Image 3D software (Xenogen Corporation, Alameda USA) and 
Matlab 7.1. Data was analyzed with ROI (region of interest) method. 
For all experiments we have used fluorescent modality, with the 
acquisition set of excitation filters: GFP (445-490nm), DsRed (500-
550nm), Cy5.5 (615-665nm), ICG background (665-695nm), ICG (710-
760nm); and the emission filter ICG (810-875nm). A 150W Quartz 
halogen 3250° Kelvin lamp at high intensity; binning factor = 8; pixel 
resolution = 0.125x0.125; field of view = 12.8cm; exposition time = 
1sec; opening of diaphragm (f/stop) = 2. 
Acquisition protocol was about a first pre acquisition and 30 post 
tracers i.v. administration acquisitions.
We have used female athymic nude-nude mice, 3-4 weeks-old; two 
dosages (1:5 and 1:10 dilution of  QDs800 commercial solution 
/0.01ml/1g body weight, i.v.) (n=6 for each group) we have observed 
the bio-distribution during three hours immediately after tracers 
administration, and n=3 for each dosage group to study time of 
elimination and tissue accumulation after 24h and 1 week from i.v. 
administration.
Tracers that we have used are nanoparticles about 10-15nm, 
semiconductors (Qtracker® 800 non-targeted quantum dots, 
InvitrogenTM Milan, Italy), constituted by a core of CdSe, a shell of 
ZnS and an amphiphilic inner coating covalently modified with a 
functionalized polyethylene glycol (PEG) outer coating.
Mice were gas anesthetized (isoflurane, Forane® Abbot s.p.a., Latina 
Italy) with XGI-8 Gas Anesthesia System (Xenogen Corporation, 
Alameda USA) and they are placed in a dorsal position on the stage, 
heated to 37°C.
Fig. 5.A. Streptavidine conjugated QDs800 excitation and emission spectri (Invitrogen, 
Milan Italy) B. 1/µa , 1/µs’, 1/ µeff path values of muscle in relationship of wavelength 
from 480 to 950 nm. Wavelengths intervals used in excitation filters (GFP, DsRed, 
Cy5.5, ICGbkg e ICG) and in emission filter (ICG em.) are marked with different colors.
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Fig. 4 Ex-vivo acquisition: 1:5 dilution of QDs800 solution /0.01ml/1g body 
weight, i.v; A. brain; B. liver; C. lungs.
Introduction
Nanotechnology represents a new frontier for the science 
progress and there are great expectations in relation to 
diagnostic and therapeutic envelopes [1]. Understanding 
of biological processes on the nanoscale level is an 
important driving force behind development of 
nanotechnology. And nanoparticles could be exploited not 
only like an incredible instrument for scientific research 
but also could be used to study behaviour of 
nanoparticles themselves because they are a typical  
product of the industrial processes and few is known 
about in vivo toxicology of nanoparticles [2]. 
In the present work we have used nanoparticles with 
optical properties, Quantum Dots (QDs) are interesting for 
the molecular, cellular and in vivo small-animal imaging 
[3]. The first studies conducted on QDs in vivo kinetics by 
using whole animal fluorescent imaging provides a 
qualitative assessment of surface-chemistry-dependent 
kinetics of these nanoparticles [4; 5]. It was very difficult to 
quantifying and localizing the uptake and the in vivo 
distribution, clearance, metabolism and toxicity [6; 7]. 
Fluorescent imaging has shown anatomical districts 
involved in QDs clearance. However measurements of 
tracking and quantification of QDs is limited by tissue 
absorption of light, which impairs excitation of QDs in 
deeper lying tissues, and decreases fluorescent light 
penetration from deeper structures from the surface of 
animals [8; 9]. 
We try to overcome the limits of tissue absorption of light 
Using particular characteristics of QDs excitation and 
emission, exploiting optical properties of tissues and 
implementing Optical Imager (VivoVision System, 
IVIS200).  
The aim of the study is to set a fully quantitative method 
to monitor nanoparticles in vivo and to study their bio-
distribution in living animals. Physiological data 
(concerning liver, brain and lung the most probably 
targets of toxicity) are extrapolated by optical parameters.
Conclusion
Optical properties of muscle tissue, referent value,  are described in Fig. 5B (Living Image 3D software, Xenogen Corporation, Alameda USA). 
To apply this method three excitation filters (Cy5.5, ICGbkg and ICG) were used to excite QDs800 accumulated in the organs and one 
emission filter (ICG) to collect the emitted radiation. Using muscle tissue optical properties, the excitation filters (Cy5.5, ICGbkg and ICG) select 
photons with 1.10, 1.48 and 1.77 cm mean free paths before absorption respectively. Still using muscle tissue optical properties photons 
emitted from QDs800 and passing the ICG emission filter have 1.67 cm of mean free path before absorption. Wavelengths selected by GFP 
and DsRed excitation filters have a lower penetration depth (less than 0.5 cm). Only nanoparticles in the superficial layer can be stimulated by 
them (Fig 5B). The higher average efficiency values in Cy5.5 , ICGbkg and ICG than DsRed excitation filters suggests that Cy5.5, ICGbkg and 
ICG filters select photons with wavelengths that can penetrate tissue with a depth useful to excite QDs800 in the hepatic region (Fig 4B). This 
consideration also suggests that Cy5.5, ICGbkg and ICG filters select photons with wavelengths that can penetrate tissue with a depth useful to 
excite QDs800 in the cerebral and pulmonary regions. This interpretation is encouraged by average efficiency of signal observed in brain, liver 
and lungs explanted from two animals administered with 1:10 dilution of  QDs800 solution (Fig 4) and by preliminar Trasmission Electron 
Microscopy data here not reported. The continuous increase in the average efficiency values using filter set, during the observed first three 
hours, encourage the interpretation that the respectively wavelengths are able to excite the nanoparticles in the liver region representing the 
continuous hepatic build up. Figure 1, 2 and 3 show the first three hours immediately after QDs administration and also the average efficiency 
on two time points of 24h and 1 week after i.v. administration.
These preliminary data suggest that we could construct an “accumulation map” of QDs800 in time. Besides using selected excitation/emission 
filters we could obtain a sort of level map of the different tissues in relation to their depth and optical characteristics.
Fig. 2. Average efficiency about kinetic of QDs800 accumulation on pulmonary region: a 3h 
continuous acquisition  immediately after i.v. administration; 24 hours and 1 weeks after i.v. 
administration. Excitation filters used: GFP, DsRed, Cy5.5, ICGbkg e ICG. Emission filter used: 
ICG 
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Fig. 1. Average efficiency about kinetic of QDs800 accumulation on cerebral region: a 3h 
continuous acquisition  immediately after i.v. administration; 24 hours and 1 weeks after i.v. 
administration. Excitation filters used: GFP, DsRed, Cy5.5, ICGbkg e ICG. Emission filter used: 
ICG 
Results
Fluorescent images of nude mice were acquired with the 
excitation/emission filters setup. To apply this method three 
excitation filters (Cy5.5, ICGbkg and ICG) were used to 
excite QDs800 accumulated in the organs and one 
emission filter (ICG) to collect the emitted radiation. In 
muscle the excitation filters select photons with 1.10, 1.48 
and 1.77 cm mean free paths before absorption 
respectively. Still in muscle photons emitted from QDs800 
and passing the ICG emission filter have 1.67 cm of mean 
free path before absorption.
Only pixels belonging to the animal body were considered. 
For each filter ICGbkg and ICG three intermediate values 
between the limits (dorsal and ventral surfaces) were 
identified to form, with the limits, five equally spaced points 
equally spaced among them. These points were 
considered the seeds for a classification process of the 
fluorescence images. The number of seeds was chosen 
arbitrarily. The average radiance was measured pixel by 
pixel and normalized to the average radiance measured 
with the Cy5.5 filter. All the pixels were ranged with a 
classification process with five classes and every class 
corresponds to a seed (Fig. 6). 
The result of classification process applied to one image is 
shown in Fig.7. The colours indicate five classes. To each 
class is associated the light path done by the photons 
before escaping from the animal surface: class 1 = 1 mm, 
class 2 = 3.5 mm, class 3 = 6 mm, class 4 =  8.5 mm and 
class 5 = 11 mm.
Fig. 7. The colours indicate five classes. To each class is associated 
the light path done by the photons before escaping from the animal 
surface: class 1 = 1 mm, class 2 = 3.5 mm, class 3 = 6 mm, class 4 =  
8.5 mm and class 5 = 11 mm.
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Fig. 6. The average radiance was measured pixel by pixel and 
normalized to the average radiance measured with the Cy5.5 filter.
All the pixels were ranged with a classification process with five 
classes and every class corresponds to a seed. 
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Fig. 3. Average efficiency about kinetic of QDs800 accumulation on hepatic region: a 3h 
continuous acquisition  immediately after i.v. administration; 24 hours and 1 weeks after i.v. 
administration. Excitation filters used: GFP, DsRed, Cy5.5, ICGbkg e ICG. Emission filter 
used: ICG 
1:5 dilution of  QDs8 0 solution
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